https://www.pynnaclestudy.com/hcp/rezatapopt/
Rezatapopt | PYNNACLE clinical study
Rezatapopt (PC14586) is a first-in-class, selective p53 reactivator specific to the TP53 Y220C mutation. PC14586 selectively reactivates p53 Y220C.
clinical studyrezatapopt